ORION 9, 10, and 11 trials

Study / Research

Trials for Inclisiran, demonstrating its LDL-lowering effects (around 50%), with women showing similar reduction.

Mentioned in 1 video

Videos Mentioning ORION 9, 10, and 11 trials

230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more

230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more

Peter Attia MD

Trials for Inclisiran, demonstrating its LDL-lowering effects (around 50%), with women showing similar reduction.